共 50 条
- [1] Prognostic Model for Progression-Free Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S657 - S657
- [7] Mature, real world progression-free survival (PFS) and overall survival (OS) milestones in stage IV, non-squamous, non-small cell lung cancer patients (nsqNSCLC) treated with first line pemetrexed(Pem)/platinum(Plat) followed by pem plus /- bevacizumab(Bev) maintenance. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)